SNMN yields 2000000.00% · PFE yields 6.13%● Live data
📍 SNMN pulled ahead of the other in Year 1
Combined, SNMN + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SNMN + PFE for your $10,000?
SNM Global Holdings, Inc., together with its subsidiaries, provides international south Asian media, entertainment, and marketing services with operations in the areas of publication, broadcast television, radio, Internet, film, television production, events, advertising, and marketing. The company publishes a weekly English language newspaper, The Indian Express North American Edition, comprising three regional editions in the United States and an edition in Canada; and Divya Bhaskar North American Edition, a weekly Gujarati language newspaper for the sub-ethnic Gujarati community in the United States and Canada, as well as has a marketing tie-up with the Telugu language newspaper, Telugu Times in North America. It also broadcasts INDIA PLUS on DIRECTV that offers news and current affairs programming for Indians in the United States; and operates as partner in the FM radio station for the south Asian community in North America. In addition, the company produces international television programming in the United States and India for south Asian TV networks; develops films for Bollywood and international markets; and produces proprietary events, such as CineMaya Media Group Indian American Achiever Awards, as well as events for clients. SNM Global Holdings, Inc. was formerly known as CineMaya Media Group, Inc. and changed its name to CineMaya Media Group, Inc. in November 2008. The company was founded in 2000 and is based in Miami, Florida with additional offices in Edison, New Jersey; Santa Clara, California; Toronto, Canada; Mumbai and Delhi, India; and Chicago, Illinois.
Full SNMN Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.